6.34
price down icon10.07%   -0.71
after-market Handel nachbörslich: 6.31 -0.03 -0.47%
loading
Schlusskurs vom Vortag:
$7.05
Offen:
$7.03
24-Stunden-Volumen:
79,522
Relative Volume:
0.24
Marktkapitalisierung:
$19.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-68.80M
KGV:
-5.4188
EPS:
-1.17
Netto-Cashflow:
$-59.06M
1W Leistung:
+11.82%
1M Leistung:
+1,815%
6M Leistung:
+999.93%
1J Leistung:
+574.47%
1-Tages-Spanne:
Value
$6.20
$7.03
1-Wochen-Bereich:
Value
$5.52
$7.6996
52-Wochen-Spanne:
Value
$0.257
$7.6996

Passage Bio Inc Stock (PASG) Company Profile

Name
Firmenname
Passage Bio Inc
Name
Telefon
(267) 866-0312
Name
Adresse
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Name
Mitarbeiter
60
Name
Twitter
@passage_bio
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
PASG's Discussions on Twitter

Vergleichen Sie PASG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PASG
Passage Bio Inc
6.34 23.21M 0 -68.80M -59.06M -1.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.41 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.14 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
330.55 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.79 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.74 31.54B 3.81B -644.79M -669.77M -6.24

Passage Bio Inc Stock (PASG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-29 Fortgesetzt Wedbush Outperform
2024-09-03 Eingeleitet Rodman & Renshaw Buy
2022-03-08 Herabstufung JP Morgan Overweight → Neutral
2022-01-19 Herabstufung Goldman Buy → Neutral
2021-07-01 Eingeleitet Raymond James Outperform
2021-06-15 Eingeleitet BTIG Research Buy
2021-03-04 Hochstufung Goldman Neutral → Buy
2021-02-04 Eingeleitet Guggenheim Buy
2021-01-25 Eingeleitet Wedbush Outperform
2021-01-04 Hochstufung JP Morgan Neutral → Overweight
2020-12-11 Eingeleitet Citigroup Neutral
2020-08-14 Herabstufung JP Morgan Overweight → Neutral
2020-06-25 Herabstufung Goldman Buy → Neutral
2020-03-25 Eingeleitet Chardan Capital Markets Buy
2020-03-24 Eingeleitet Cowen Outperform
2020-03-24 Eingeleitet Goldman Buy
2020-03-24 Eingeleitet JP Morgan Overweight
Alle ansehen

Passage Bio Inc Aktie (PASG) Neueste Nachrichten

pulisher
06:19 AM

Real time social sentiment graph for Passage Bio Inc.Free Low Drawdown Real Time Trading Tips - Newser

06:19 AM
pulisher
06:17 AM

Will Passage Bio Inc. Stock Benefit from AI and Green Energy TrendsTrend Reversal Probability Forecast Update - Newser

06:17 AM
pulisher
05:38 AM

Historical volatility pattern of Passage Bio Inc. visualizedFree Oversold Recovery Opportunity Stocks - Newser

05:38 AM
pulisher
05:23 AM

What analysts say about Passage Bio Inc. stock outlookMonthly Long-Term Market Recap and Summary - Newser

05:23 AM
pulisher
05:21 AM

Why Passage Bio Inc. stock attracts strong analyst attentionAI Entry Timing Prediction for Swing Traders - Newser

05:21 AM
pulisher
Jul 28, 2025

How strong is Passage Bio Inc. company’s balance sheetRetirement Planning Forecasts For Consistent Profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What machine learning models say about Passage Bio Inc.Forecasting Stock Moves with AI Insights - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What moving averages say about Passage Bio Inc. Weekly Breakout Forecast with Entry Zones - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What machine learning models say about Passage Bio Inc. Accurate Forecast System with AI Support - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

Does Passage Bio Inc. stock perform well during market downturnsExplosive trading opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Passage Bio Inc. stockBreakout stock performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are Passage Bio Inc. company’s key revenue driversBuild a diversified portfolio for risk management - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Passage Bio Inc.Superior trading gains - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Passage Bio Inc. in the next 12 monthsDiscover breakthrough stocks with expert help - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Passage Bio Inc. Stock a Good Fit for Conservative InvestorsRisk Controlled Trading Ideas - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Passage Bio Skyrockets 31.04%—Is Institutional Buying the Catalyst for a Biotech Breakout? - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Passage Bio Inc. stockFree Trading Psychology Coaching - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Passage Bio Soars 12.39% on Institutional Buying Spree - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Passage Bio Inc. stock priceAccelerated financial growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Passage Bio Inc. Stock Analysis and ForecastHigh-performance investment picks - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Will Passage Bio Inc. stock benefit from interest rate changesAccelerated earnings growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What makes Passage Bio Inc. stock price move sharplyStable Growth Stock Picks - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

Lynx1 capital buys Passage Bio (PASG) shares worth $733,825 - Investing.com

Jul 24, 2025
pulisher
Jul 23, 2025

Is Passage Bio Inc. a good long term investmentFree Stock Movement Tracking - jammulinksnews.com

Jul 23, 2025

Finanzdaten der Passage Bio Inc-Aktie (PASG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Passage Bio Inc-Aktie (PASG) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Lynx1 Capital Management LP
10% Owner
Jul 23 '25
Buy
5.74
49,302
283,033
525,273
Lynx1 Capital Management LP
10% Owner
Jul 22 '25
Buy
5.44
13,123
71,338
475,971
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Kapitalisierung:     |  Volumen (24h):